Huguet, Françoise <br/><br/>
Nilotinib efficacy, safety, adherence and impact on quality of life in newly diagnosed patients with chronic myeloid leukaemia in chronic phase: a prospective observational study in daily clinical practice.  [electronic resource] 

 -  British journal of haematology  12 2019 
 - 615-626 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/bjh.16145  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Asthenia--chemically induced<br/>Biomarkers, Tumor--genetics<br/>Drug Eruptions--etiology<br/>Female<br/>Follow-Up Studies<br/>Fusion Proteins, bcr-abl--genetics<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pruritus--chemically induced<br/>Psychometrics<br/>Pyrimidines--adverse effects<br/>Quality of Life<br/>Treatment Outcome<br/>Young Adult<br/>Assessment of Medication Adherence